Naloxone Mechanism and Efficacy
Opioid Reversal
- Naloxone prevents or reverses central nervous system effects of opioids, including respiratory depression, sedation, hypotension, and analgesia, by competing for opioid receptor sites in the CNS, with the American Gastroenterological Association noting its effectiveness 1
- The American Society of Clinical Oncology recommends naloxone for reversing the effects of morphine, codeine, and fentanyl 2
- The European Society for Medical Oncology notes that naloxone fully reverses the effects of oxycodone and hydromorphone 3, 5
- The American College of Physicians states that naloxone is effective in reversing the effects of methadone, tramadol, and tapentadol 4, 6
Non-Opioid Drug Effects
- Naloxone is ineffective for reversing effects of non-opioid drugs, including benzodiazepines, barbiturates, and other sedative-hypnotics, as noted by the American Gastroenterological Association 1
Duration and Dosing
- The onset of action after intravenous naloxone is 1-2 minutes, with a half-life of 30-45 minutes, according to the American Gastroenterological Association 1
- Initial dosing is typically 0.2-0.4 mg (0.5-1.0 μg/kg) intravenously every 2-3 minutes until desired response, with monitoring for up to 2 hours, as recommended by the American Gastroenterological Association 1
- The American Society of Clinical Oncology notes that intranasal and intramuscular formulations of naloxone are effective for opioid overdose reversal 7
Safety Warning
- Naloxone precipitates acute opioid withdrawal in physically dependent patients, which can manifest as agitation, nausea, vomiting, tremor, tachycardia, hypertension, seizures, and potentially life-threatening complications, as warned by the American Society of Clinical Oncology 7